Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.

The American Heart Association says heart diseases are the leading cause of death in the US. Experts tell Digital Trends that ...

For many people, medications may be needed to treat high blood pressure, but for everyone making lifestyle changes can make a ...

Yes, you read that right! A well-planned and balanced diet plays the most crucial role in cancer prevention. You may consider ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...